knowledge -WSS

knowledge

author：comprehensive 2025-09-06 01:55:30 - browse：373

Steven Pearson — ICER President Steven D. Pearson Craig F. Walker/The Boston Globe

Meetings of the Institute for Clinical and Economic Review don’t usually get one’s heart pumping. But a meeting Thursday at the Massachusetts Institute of Technology may prove to be the exception to that rule.

Patients Rising Now, an advocacy group that says it promotes transparency in health care and that is a fierce opponent of ICER’s, is expected to face off with the self-professed “watchdog of drug pricing” as it reviews three drugs for Duchenne muscular dystrophy.

Dozens of Duchenne patients and their families — many of whom also express concern that ICER’s review could undermine insurers’ already tepid interest in the treatments — are also expected to be in attendance.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Will the market for weight loss drugs really reach $100 billion?

focus

WSS

Fetal surgery at risk from Dobbs and new abortion restrictions

U.K. Biobank has 500,000 peoples' genome sequences available

Fetal surgery at risk from Dobbs and new abortion restrictions

Create a giant ice tray with this foil pan hack to keep food cold this summer

Presidential fundraising highlights so far: Trump brings in more than DeSantis

UnitedHealth’s Optum accused of antitrust violations in California

hotspot

knowledge

entertainment

Apple is now the first public company to be valued at $3 trillion

Create a giant ice tray with this foil pan hack to keep food cold this summer

Supreme Court strikes down use of affirmative action

Flagship Pioneering launches a new biotech in two countries

Dobbs anniversary: the lost opportunity of abortion as health care

White House announces new plan to address the growing threat of xylazine in overdose crisis

Psychedelics group wrestles with new pharma identity

As biotech industry slumps, bioscience job market is upside down

Affirmative action in medical school literally saved lives

U.K. Biobank has 500,000 peoples' genome sequences available

focus

Swim instructor mom warns parents not to buy blue swimsuits for kids

Organ aging and disease risk measured by new blood test

Diagnostic tests are hitting their mathematical limits

Flagship Pioneering launches a new biotech in two countries

Organ aging and disease risk measured by new blood test

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

focus

focus

hotspot

focus